INSP Share Price | Inspire Medical Systems, Inc. Stock Analysis & Recommendation

Q: How big is Inspire Medical Systems, Inc.?

Market Cap: As of Jun 18, Inspire Medical Systems, Inc. has a market capitalization of 3,753.10 million, categorizing it as a Mid Cap company.Recent Quarterly Performance: For the latest four quarters, Inspire Medical Systems reported net sales of 840.11 million and a net profit of 66.50 million.Balance Sheet Snapshot: As of Dec 24, the company's shareholder's funds amounted to 689.70 million, while total assets were reported at 808.38 million.

Q: What does Inspire Medical Systems, Inc. do?

Overview:Inspire Medical Systems, Inc. is a medical technology company focused on developing and commercializing minimally invasive solutions for patients with obstructive sleep apnea, operating within the Pharmaceuticals & Biotechnology industry and classified as a mid-cap company.Financial Snapshot:Most recent Net Sales: 201 Million (Quarterly Results - Mar 2025) Most recent Net Profit: 3 Million (Quarterly Results - Mar 2025) Market cap: USD 3,753.10 Million (Mid Cap)Key Metrics:P/E: 60.00 Dividend Yield: 0.00% Debt Equity: -0.58 Return on Equity: 10.46% Price to Book: 5.90 Contact Details:Address: 5500 Wayzata Blvd Ste 1600, GOLDEN VALLEY MN: 55416-1237 Tel: 1 763 9575037 Website: http://www.inspiremedicalsystems.com

Q: Is Inspire Medical Systems, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Inspire Medical Systems, Inc. has moved from attractive to fair. The company appears to be overvalued based on its current financial metrics. Key ratios include a P/E ratio of 60, an EV to EBITDA of 62.23, and a PEG ratio of 0.12, which suggests that the stock is priced high relative to its earnings growth potential.In comparison to its peers, Inspire Medical Systems has a P/E ratio significantly higher than QIAGEN NV at 24.20 and Bio-Rad Laboratories, Inc. at 16.20, both of which are considered fair. Additionally, while Inspire's PEG ratio is low at 0.12, indicating potential undervaluation in terms of growth, the overall high valuation ratios suggest it is not justified at the current price level. Over the past year, Inspire Medical Systems has underperformed significantly, with a return of -60.44% compared to the S&P 500's 14.08%, reinforcing the notion that the stock may be overvalued.

Q: Is Inspire Medical Systems, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Inspire Medical Systems, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including a bearish signal from the daily moving averages, as well as bearish readings from the KST and Bollinger Bands on both weekly and monthly time frames. The MACD shows a conflicting mildly bullish signal on the weekly but is bearish on the monthly, indicating weakness in the longer-term trend. Additionally, the stock has significantly underperformed the S&P 500, with a year-to-date return of -58.18% compared to the S&P 500's 15.47%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

800.53 k

Shareholding (Dec 2025)

FII

24.72%

Held by 204 FIIs

DII

Held by 76 DIIs

Promoter

11.97%

How big is Inspire Medical Systems, Inc.?

22-Jun-2025

As of Jun 18, Inspire Medical Systems, Inc. has a market capitalization of $3.75 billion, with net sales of $840.11 million and a net profit of $66.50 million over the latest four quarters. The company's shareholder's funds are $689.70 million, and total assets amount to $808.38 million.

View full answer

What does Inspire Medical Systems, Inc. do?

22-Jun-2025

Inspire Medical Systems, Inc. is a mid-cap medical technology company that develops minimally invasive solutions for obstructive sleep apnea. As of March 2025, it reported net sales of $201 million and a net profit of $3 million.

View full answer

Who are in the management team of Inspire Medical Systems, Inc.?

22-Jun-2025

As of March 2022, the management team of Inspire Medical Systems, Inc. includes Marilyn Nelson (Independent Chairman), Timothy Herbert (CEO), and directors Shelley Broader, Georgia Garinois-Melenikiotou, Gary Ellis, Jerry Griffin, and Shawn McCormick. They are responsible for the company's strategic direction and operations.

View full answer

Is Inspire Medical Systems, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Inspire Medical Systems, Inc. is considered overvalued with a valuation grade of fair, reflected by a high P/E ratio of 60 and significant underperformance of -60.44% over the past year compared to the S&P 500's 14.08%.

View full answer

Is Inspire Medical Systems, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Inspire Medical Systems, Inc. has shifted to a bearish trend, supported by negative signals from moving averages, KST, and Bollinger Bands, while underperforming the S&P 500 with a year-to-date return of -58.18%.

View full answer

Compare Inspire Medical Systems, Inc. with Similar Stocks

Bausch + Lomb Corp.Dentsply Sirona, Inc.Shockwave Medical, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor Management Efficiency with a low ROE of 2.09%

The company has been able to generate a Return on Equity (avg) of 2.09% signifying low profitability per unit of shareholders funds

With ROE of 10.46%, it has a attractive valuation with a 6.31 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 1,702 Million (Small Cap)

P/E

42.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.39

Return on Equity

19.13%

Price to Book

2.18

Revenue and Profits:

Net Sales:

269 Million

(Quarterly Results - Dec 2025)

Net Profit:

136 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-46.56%

6 Months

-25.83%

1 Year

-65.39%

2 Years

-62.66%

3 Years

-73.97%

4 Years

-71.52%

5 Years

-70.77%

Inspire Medical Systems, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

51.21%

EBIT Growth (5y)

23.79%

EBIT to Interest (avg)

-15.13

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.58

Sales to Capital Employed (avg)

1.17

Tax Ratio

7.59%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

3.71%

ROE (avg)

2.09%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.53

EV to EBIT

50.50

EV to EBITDA

40.06

EV to Capital Employed

5.52

EV to Sales

2.43

PEG Ratio

0.05

Dividend Yield

ROCE (Latest)

10.92%

ROE (Latest)

8.43%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 108 Schemes (68.52%)

Foreign Institutions

Held by 204 Foreign Institutions (24.72%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 12.27% vs 24.52% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 286.65% vs 137.84% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "269.10",
          "val2": "239.70",
          "chgp": "12.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49.90",
          "val2": "34.40",
          "chgp": "45.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "136.10",
          "val2": "35.20",
          "chgp": "286.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "171.40%",
          "val2": "133.00%",
          "chgp": "3.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.60% vs 28.49% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 171.78% vs 352.36% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "912.00",
          "val2": "802.80",
          "chgp": "13.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "64.90",
          "val2": "42.60",
          "chgp": "52.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "145.40",
          "val2": "53.50",
          "chgp": "171.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "55.90%",
          "val2": "44.90%",
          "chgp": "1.10%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

269.10

239.70

12.27%

Operating Profit (PBDIT) excl Other Income

49.90

34.40

45.06%

Interest

0.10

0.00

Exceptional Items

0.00

Consolidate Net Profit

136.10

35.20

286.65%

Operating Profit Margin (Excl OI)

171.40%

133.00%

3.84%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 12.27% vs 24.52% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 286.65% vs 137.84% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

912.00

802.80

13.60%

Operating Profit (PBDIT) excl Other Income

64.90

42.60

52.35%

Interest

0.10

0.00

Exceptional Items

-4.00

0.00

Consolidate Net Profit

145.40

53.50

171.78%

Operating Profit Margin (Excl OI)

55.90%

44.90%

1.10%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 13.60% vs 28.49% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 171.78% vs 352.36% in Dec 2024

All Annual Results

Company CV

About Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc.

Pharmaceuticals & Biotechnology

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the developing and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The Company has developed a novel, closed-loop solution that continuously monitors a patient's breathing patterns and delivers mild hypoglossal nerve stimulation to maintain an open airway. The system delivers mild stimulation to the hypoglossal nerve, which controls the movement of user's tongue and other key airway muscles. By stimulating these muscles, the airway remains open during sleep. The system is controlled by a small handheld sleep remote.

Company Coordinates

Company Details

5500 Wayzata Blvd Ste 1600 , GOLDEN VALLEY MN : 55416-1237

Tel: 1 763 9575037

http://www.inspiremedicalsystems.com

Registrar Details